We are live on ! Find out more
BCM

Bourgeon Capital Management Portfolio holdings

AUM $679M
1-Year Est. Return 50.89%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+783.94%
AUM
$429M
AUM Growth
+$8.73M
Cap. Flow
-$4.07M
Cap. Flow %
-0.95%
Top 10 Hldgs %
33.96%
Holding
360
New
39
Increased
44
Reduced
62
Closed
23

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.28M
2
TER icon
Teradyne
TER
+$2.82M
3
FCX icon
Freeport-McMoran
FCX
+$2.73M
4
MU icon
Micron Technology
MU
+$1.94M
5
PH icon
Parker-Hannifin
PH
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 20.35%
2 Healthcare 17.84%
3 Industrials 12.94%
4 Financials 12.24%
5 Energy 12.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SG icon
351
Sweetgreen
SG
$698M
-1,000
Closed -$7.84K
TXN icon
352
Texas Instruments
TXN
$254B
-3,000
Closed -$558K
VBR icon
353
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.7B
-193
Closed -$30.6K
VFF icon
354
Village Farms International
VFF
$248M
-2,000
Closed -$1.66K
VTRS icon
355
Viatris
VTRS
$19B
-63
Closed -$607
NBIS
356
Nebius Group N.V.
NBIS
$48.2B
$0 ﹤0.01%
100
FTCH
357
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-12,500
Closed -$61.4K
GER
358
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
-198,998
Closed -$2.61M
DCP
359
DELISTED
DCP Midstream, LP
DCP
-169
Closed -$7.05K
LBPH
360
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
-49,855
Closed -$200K

Similar funds

Bourgeon Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bourgeon Capital Management held 360 positions worth $429M, up 2.1% from $420M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Bourgeon Capital Management's Q2 2023 filing shows 39 new, 44 increased, 62 reduced and 23 closed positions. Its largest new stake was Teva Pharmaceuticals: 651,760 shares worth $4.91M. The largest sale was Jacobs Solutions, an estimated $7.04M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Bourgeon Capital Management's largest Q2 2023 buy was Teva Pharmaceuticals: 651,760 shares worth $4.91M.
  • Bourgeon Capital Management added most to Teradyne in Q2 2023, an estimated $2.82M increase.
  • Bourgeon Capital Management's biggest Q2 2023 reduction was Jacobs Solutions, cutting an estimated $7.04M.
  • Bourgeon Capital Management fully exited Goldman Sachs MLP Energy Renaissance Fund in Q2 2023, selling an estimated $2.61M.
  • Bourgeon Capital Management's ten largest holdings make up 34% of its $429M portfolio in Q2 2023.
  • Bourgeon Capital Management opened 39 new positions and closed 23 in Q2 2023.
  • Bourgeon Capital Management's portfolio value rose 2.1% quarter-over-quarter to $429M.

Based on Bourgeon Capital Management's 13F filing for Q2 2023, filed 20 Jul 2023.